Double maintains 1 strategies that include ATXS - Astria Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 56.44% | $1.95B | -15.67% | 0.00% |
DNLI | 56.13% | $2.06B | -30.04% | 0.00% |
XENE | 54.41% | $2.27B | -26.70% | 0.00% |
CRNX | 53.80% | $2.92B | -39.88% | 0.00% |
APGE | 52.01% | $2.42B | -24.39% | 0.00% |
IDYA | 49.75% | $1.52B | -58.32% | 0.00% |
IMNM | 48.94% | $696.10M | -44.44% | 0.00% |
BEAM | 48.68% | $1.73B | -27.49% | 0.00% |
RGNX | 48.10% | $433.39M | -46.03% | 0.00% |
SITE | 48.03% | $5.50B | -19.85% | 0.00% |
COGT | 47.58% | $543.09M | -36.14% | 0.00% |
SNDX | 47.51% | $770.13M | -57.22% | 0.00% |
IVZ | 47.17% | $6.86B | -4.79% | 5.38% |
JLL | 46.94% | $11.18B | +13.49% | 0.00% |
NRIX | 46.72% | $721.19M | -38.57% | 0.00% |
ZYME | 46.69% | $810.02M | +22.92% | 0.00% |
EYPT | 46.16% | $393.60M | -54.31% | 0.00% |
ACLX | 46.16% | $3.22B | +10.72% | 0.00% |
NMRK | 46.14% | $2.15B | +6.50% | 1.28% |
CLDX | 46.00% | $1.33B | -49.67% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -23.32% | $45.74M | -99.96% | 0.00% |
CBOE | -14.94% | $22.95B | +20.67% | 1.12% |
VZ | -12.20% | $183.32B | +8.02% | 6.21% |
K | -10.97% | $28.49B | +32.17% | 2.77% |
VSTA | -10.30% | $326.82M | +11.64% | 0.00% |
LITB | -9.50% | $21.28M | -72.45% | 0.00% |
NOC | -8.45% | $67.51B | -0.35% | 1.76% |
AQB | -7.68% | $2.96M | -61.58% | 0.00% |
CME | -7.62% | $98.74B | +28.80% | 3.84% |
ED | -7.22% | $36.75B | +5.26% | 3.28% |
CL | -6.58% | $72.64B | -5.18% | 2.25% |
HSY | -5.44% | $33.16B | -21.37% | 3.44% |
ZCMD | -4.91% | $32.45M | -11.38% | 0.00% |
VHC | -4.91% | $34.69M | +74.89% | 0.00% |
MO | -4.64% | $97.80B | +26.35% | 6.94% |
OHI | -4.25% | $10.52B | +18.48% | 7.38% |
AEP | -4.25% | $54.28B | +9.80% | 3.61% |
PPC | -3.81% | $11.21B | +41.54% | 0.00% |
KMB | -3.53% | $45.57B | +1.99% | 3.58% |
COR | -3.38% | $55.43B | +28.90% | 0.56% |
Yahoo
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Yahoo
BOSTON, May 13, 2025--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the first quarter ended March 31, 2025, and provided a corporate update.
Finnhub
Astria Therapeutics Inc: * ASTRIA THERAPEUTICS Q1 OPERATING EXPENSES USD 36.995MILLION * ASTRIA THERAPEUTICS Q1 INCOME FROM OPERATIONS USD -36.995MILLION *...
Yahoo
BOSTON, May 02, 2025--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 33,650 shares of Astria’s common stock on May 1, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee of Astria.
Finnhub
BOSTON - Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that results from a Phase 1a trial...
Yahoo
BOSTON, May 01, 2025--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that results from a Phase 1a trial in healthy subjects supporting navenibart’s potential to provide long-acting, safe, and effective attack prevention for hereditary angioedema (HAE) with dosing every 3 and 6 months have been published in the Annals of Allergy, Asthma & Immunology.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
QXO | 0.30% | $8.44B | -84.99% | 0.00% |
GFI | -0.31% | $18.61B | +31.67% | 2.75% |
SO | -0.41% | $96.04B | +10.08% | 3.29% |
UTZ | -0.46% | $1.11B | -29.27% | 1.86% |
FUBO | -0.70% | $1.01B | +121.80% | 0.00% |
PHYS.U | 0.72% | - | - | 0.00% |
TEF | -0.79% | $27.20B | +8.80% | 6.44% |
UUU | 0.79% | $4.93M | +40.20% | 0.00% |
RILY | 0.81% | $102.47M | -88.22% | 14.71% |
LMT | 0.85% | $108.98B | +0.07% | 2.79% |
ASPS | -0.86% | $69.98M | -57.72% | 0.00% |
CYCN | 0.95% | $9.37M | +2.39% | 0.00% |
BNED | 1.08% | $371.19M | -38.80% | 0.00% |
CNC | 1.09% | $29.89B | -22.14% | 0.00% |
AWK | -1.14% | $27.37B | +4.54% | 2.22% |
AMT | 1.25% | $99.10B | +8.59% | 3.09% |
ADC | 1.28% | $8.13B | +22.47% | 4.08% |
EXC | -1.33% | $43.84B | +12.45% | 3.59% |
CHD | -1.35% | $23.29B | -11.36% | 1.23% |
AGL | -1.39% | $1.06B | -54.30% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 63.77% | $4.85B | 0.35% |
GNOM | 59.36% | $40.65M | 0.5% |
IBB | 58.88% | $5.22B | 0.45% |
IWC | 57.97% | $766.88M | 0.6% |
PBE | 57.53% | $214.12M | 0.58% |
ARKG | 54.67% | $944.78M | 0.75% |
IWO | 54.43% | $11.36B | 0.24% |
XPH | 54.28% | $136.58M | 0.35% |
IWM | 54.01% | $63.95B | 0.19% |
VTWO | 54.00% | $12.07B | 0.07% |
SCHA | 53.01% | $16.91B | 0.04% |
PINK | 52.98% | $131.52M | 0.5% |
KJUL | 52.28% | $113.35M | 0.79% |
KJAN | 52.16% | $305.13M | 0.79% |
GSSC | 52.04% | $538.65M | 0.2% |
IWN | 51.94% | $11.10B | 0.24% |
PRFZ | 51.78% | $2.33B | 0.34% |
PTH | 51.70% | $96.56M | 0.6% |
ESML | 51.69% | $1.81B | 0.17% |
ISCG | 51.69% | $645.00M | 0.06% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CGSD | 0.23% | $1.19B | 0.25% |
USDU | 0.26% | $173.44M | 0.5% |
UTEN | -0.27% | $192.72M | 0.15% |
GSY | -0.33% | $2.79B | 0.22% |
STIP | -0.41% | $11.88B | 0.03% |
SHYM | -0.44% | $322.93M | 0.35% |
KRBN | 0.45% | $160.09M | 0.85% |
BSV | -0.52% | $38.35B | 0.03% |
IBTF | -0.66% | $2.12B | 0.07% |
GOVT | 0.68% | $27.25B | 0.05% |
IBTP | 0.71% | $129.44M | 0.07% |
JPST | 0.72% | $30.82B | 0.18% |
LGOV | 0.82% | $684.47M | 0.67% |
IEF | -0.83% | $34.17B | 0.15% |
IBTO | -0.92% | $330.69M | 0.07% |
SPTI | -0.93% | $8.70B | 0.03% |
JPLD | 0.98% | $1.19B | 0.24% |
JSI | 0.99% | $729.68M | 0.49% |
CANE | 1.17% | $10.71M | 0.29% |
SMB | -1.19% | $269.10M | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -38.63% | $361.41M | 1.43% |
VIXY | -37.85% | $109.64M | 0.85% |
TAIL | -36.47% | $140.49M | 0.59% |
FXY | -19.01% | $838.61M | 0.4% |
IVOL | -17.14% | $353.94M | 1.02% |
IBMN | -14.12% | $446.12M | 0.18% |
ULST | -12.23% | $637.77M | 0.2% |
SPTS | -11.14% | $5.76B | 0.03% |
XONE | -10.81% | $603.24M | 0.03% |
CTA | -10.10% | $1.05B | 0.76% |
UTWO | -8.86% | $387.71M | 0.15% |
TPMN | -8.25% | $31.54M | 0.65% |
IBTG | -8.22% | $1.88B | 0.07% |
CORN | -8.09% | $49.57M | 0.2% |
FTSD | -7.86% | $212.46M | 0.25% |
UNG | -7.79% | $371.83M | 1.06% |
STPZ | -7.73% | $446.46M | 0.2% |
GBIL | -7.68% | $6.17B | 0.12% |
VGSH | -7.42% | $22.38B | 0.03% |
UDN | -7.07% | $137.74M | 0.78% |
Current Value
$3.991 Year Return
Current Value
$3.991 Year Return